Production of pharmaceutical proteins by transgenic animals. Aggregation of therapeutic proteins edited by wei wang christopher j. Recent advances in therapeutic protein drug development. Recovery and purification of plantmade recombinant proteins.
Plant molecular farming for recombinant therapeutic proteins ph. Plant molecular farming for recombinant therapeutic proteins. This article will discuss the transfer of genes from one species to another in order to endow the recipient species with beneficial properties, or to enable the recipient to produce human proteins for injection into human patients who lack a vitally important protein. The first recombinant therapeutic protein produced in mammalian cells, tissue plasminogen activator rtpa. Pdf production of therapeutic proteins through plant tissue and. A wellcharacterized example of an nglycosylation pattern affecting therapeutic ef. Advancements in the field of biotechnology have increased and facilitated the production of therapeutically significant proteins to combat various fatal diseases. The current achievements and growth of plant biotechnology research are a direct result of the initiative and effort put forth by numerous. The 6 kda early secretory antigenic target esat6 and culture filtrate protein 10 cfp10 proteins are among the key cell virulence factors of mtb and have been expressed in transgenic carrot plants, where esat6 makes up plantmade pharmaceuticals pmps hold great promise for helping produce and potentially enable new ways to treat a wide range of diseases and conditions, including cancer, arthritis and cystic fibrosis.
Production of therapeutic proteins in plants uc anr catalog. The most important prerequisite of any expression systems is that it should be simple and. A large advantage which plant expression systems have over conventional therapeutic protein production platforms is the ability to produce protein rapidly, going from gene sequence to grams of protein in under a month using transient expression techniques rybicki, 2010. Biopharmaceuticals derived from genetically modified plants. Pmps are in various stages of development for use in the production of existing as well as new treatments for a range of therapeutic needs. Platforms for plantbased protein production springerlink. Thus, efforts are being made in order to eliminate, or at least minimize, plant specific n. Current topics in microbiology and immunology, vol 240. The production of these compounds in plants is sometimes called molecular pharming. The first full size native protein expressed in plants was human serum albumin, produced in 1990 in transgenic tobacco and potato plants. Recombinant protein therapeutics from cho cells 20 years. This therapeutic approach in treating diseases using proteins and peptides is termed protein therapeutics. The increasing value of plantmade proteins sciencedirect.
Proteins prepared from plants haveverylittle chance to contain pathogens for humans or animals. It is also possible to deliver genes into the separate genome of plastids chloroplasts and mitochondria in plant cells. Currently, most of all recombinant therapeutic proteins are produced in mammalian cells because mammalian cells are capable of producing highquality proteins similar to the naturally occurring ones. Vaccines are another important group of pharmaceutical products of recombinant dna technology.
Production of therapeutic proteins in plants slideshare. Production of therapeutic proteins by gene transfer. Other therapeutic proteins are being developed and are currently at various stages of the pipeline. The production of highvalue proteins in plants is maturing, as shown by the recent approval of innovative products and the latest studies that showcase plant based production systems using technologies and approaches that are well established in other fields. Production of therapeutic proteins by genetic engineering. Advances in the production of human therapeutic proteins. Plant expression platform for the production of recombinant. Apart from this, economics, scalability and challenges of plant made therapeutics are discussed. Recombinant pharmaceutical protein production in plants. Despite many advantages plants offer as hosts for expression of recombinant proteins, there are certain limitations caused by major structural differences between plant and mammalian nlinked glycans. Production of therapeutic proteins through plant tissue and cell culture. For example, therapeutic proteins currently purified.
One major concern is the uncontrolled dissemination of the proteins thus of the antigens when plants are cultured in. Table 1 comparison of recombinant protein production in plants, yeast and mammalian systems. Transgenic production enables the development of certain scarce and valuable human proteins. Human growth hormone, initially produced in tobacco and sun. Protein therapy is similar to gene therapy, but unlike gene therapy, protein therapy delivers protein to the body in specific amounts as would be ordinarily present, to help repair illness, treat pain or remake structures. Much progress has been made towards the development of manufacturing infrastructure for plant made pharmaceuticals pmp, which typically consist of recombinant proteins applied as vaccine antigens, therapeutic enzymes, or monoclonal antibodies. Plant based mucosal vaccines and orally delivered therapeutic dietary proteins oral delivery of recombinant plant produced vaccines is a conceptually desirable route of vaccination due to the simplicity and. Plant based vaccine technologies involve the integration of the desired genes encoding the antigen protein for specific disease into the genome of plant tissues by various methods. The term biopharmaceutical appears to be originated in the 1980s and is used to refer to therapeutic proteins produced by. The concept of using plants to produce recombinant pharmaceutical proteins, referred to as plant molecular farming pmf or pharming pmp, is not new. These recombinant therapeutic proteins are produced using many different plant based platforms including cells and field crops. Genentech, usa as the first therapeutic protein from recombinant mammalian cells in 1986 triggered the emergence of mammalian cell culture as the industrys workhorses for biopharmaceutical production. Anr publication 8078 production of therapeutic proteins in plants 5.
Transgenic plant recombinant protein gauche disease therapeutic protein. Protalix biotherapeutics develops recombinant human proteins and produces them in plant cell culture. Using transgenic plants to prepare recombinant proteins raise little ethical problems. Their size and complexity make chemically synthesizing proteins incredibly difficult, so these new drugs must be produced biologically using the. Although a variety of alternative expression systems exists, such as microbial, insect, transgenic animal and plants, mammalian. Other examples of recombinant protein pharmaceuticals in plants followed and early descriptions include human serum albumin 3 and hepatitis b surface antigen hbsag 4. The 6 kda early secretory antigenic target esat6 and culture filtrate protein 10 cfp10 proteins are among the key cell virulence factors of mtb and have been expressed in transgenic carrot plants, where esat6 makes up storage protein in carrot storage roots. The muteins obtained by protein engineering technique are considered as second generation of therapeutic proteins. Therapeutic recombinant protein production in plants. Agrobacterium mediated gene transfer and transformation via genetically modified plant virus are the common methods that have been used to produce effective vaccines.
Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Guidelines on the quality, safety, and efficacy of. Cho cells in biotechnology for production of recombinant. While substantial progress has been made in recent years. Engineering of therapeutic proteins 157 posttranslational modification, protein fusions, and genetic engineering, as illustrated in figure 7. In comparison to bacterial, yeast and animal cells, the production of recombinant proteins in plants with economic and therapeutic importance has only started recently. Plantmade pharmaceuticals pmps biopharming involves the use of genetically modified gm plants or plant cells to produce proteins of therapeutic value. A number of therapeutic proteins have been produced in plants, some. Biologists often define pharmaceutical crops as genetically modified gm or engineered crops to produce vaccines, antibodies, and other therapeutic proteins 14, but sometimes, other terms for such a class of crops or practice are used. Nglycosylation of recombinant therapeutic glycoproteins.
In addition, many approved recombinant therapeutic proteins are generated in li due to its wellcharacterized genetics, rapid growth, and high. Maelor davies university of kentucky lexington, ky the development of plant genetic transformation in the early 980s introduced the possibility of having plants express nonnative foreign genes, and thereby accumulate nonnative proteins in their cells and tissues. Humanization of plant made vaccines and therapeutic proteins can be accomplished by incorporating the necessary glycosylation pathways in transgenic plants, as well as producing knockout plants which no longer produce the specific glycosylation motifs prone to cause adverse effects in humans. The first report of a plantmade therapeutic pmt protein reaching phase ii human clinical trials was made by biolex therapeutics, inc. Genes that encode high value pharmaceutical proteins are. These recombinant therapeutic proteins are produced using many different plantbased platforms including cells and field crops. There is an increasing demand for the generation of recombinant pharmaceutical proteins for a wide array of therapeutic applications. Pharmaceutical products of recombinant dna technology. It is also possible to deliver genes into the separate genome of plastids chloroplasts and mitochondria in plant. For example, pharma crops is used to designate transgenic plants for the.
Pdf plant molecular farming is simply defined as the production of proteins. A biopharmaceutical, also known as a biological medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Plant based alternatives to animal proteins are increasing in prevalence and quality, but for many applications they are not currently able to fully emulate the sensory and functional properties of animal proteins. The current treatment of patients involves weekly administration of an ifn. Transgenic plants in production of enzymes, therapeutic protein and antibodies within the last decade plants genetic engineering has become a cornerstone of the expanding biotechnology revolution. Years after this pioneering work, two plant derived pharmaceuticals pdps or plant made pharmaceuticals pmps have been. Transgenic plants in production of enzymes, therapeutic. Even you can use the pulp left after extracting the juice from papaya as poultice on the wounds. Transgenic plants as biofactories for the production of. Such deviations, however, do not automatically have an actual imtechnical report recombinant therapeutic proteins. Transgenic technology in the production of therapeutic. Taliglucerase alfa has been the first biotherapeutic expressed in plant cells to be approved by regulatory authorities around the world.
1103 726 494 840 803 859 1176 1267 397 390 207 663 1300 1306 1330 900 1198 999 211 113 160 491 8 1 480 878 25 108 748 150 674 921 800 649 1341 1426